News | August 17, 2020
BMS Licenses IL-12 from Dragonfly in $475 Million Upfront Deal
Read More
News | July 29, 2020
Women in Bio: Geeta Vemuri Blazes a Trail in Venture Capital
Read More
Press Release | July 27, 2020
CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy
Read More
News | July 23, 2020
Clearing the Hurdles to a Career in Venture Capital; An Interview with Geeta Vemuri
Read More
